FIELD: medicine. SUBSTANCE: method involves the use of taurine as membrane-stabilizing agent both at insulin-dependent and insulin-independent diabetes mellitus that provides the significant improvement of patient state and stabilization of process course. EFFECT: enhanced effectiveness of treatment. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LIPID METABOLISM MODIFICATION | 1996 |
|
RU2071379C1 |
METHOD FOR ADJUSTING METABOLISM DISORDERS IN DIABETES MELLITUS PATIENTS | 1996 |
|
RU2157692C2 |
METHOD FOR NONMEDICAMENTOUS CORRECTION OF IMMUNE DISORDERS IN PATIENTS AFFECTED WITH NEWLY DETECTED INSULIN-DEPENDENT DIABETES MELLITUS | 1994 |
|
RU2089164C1 |
MEANS FOR TREATING INSULIN RESISTANCE | 1999 |
|
RU2158590C1 |
METHOD OF TREATING INSULIN-DEPENDENT DIABETES MELLITUS | 0 |
|
SU1561263A1 |
AGENT FOR CORRECTION OF METABOLIC SYNDROME AND METHOD OF TREATMENT OF VASCULAR COMPLICATIONS INDUCED BY CARBOHYDRATE METABOLISM IMPAIRMENT | 2001 |
|
RU2185826C1 |
METHOD OF CORRECTING INSULIN DOSAGE IN TREATING DIABETES MELLITUS | 1991 |
|
RU2009511C1 |
METHOD OF TREATMENT OR EARLY LIPID METABOLISM DISTURBANCE IN PATIENT WITH DIABETES OF THE 1-TYPE | 1992 |
|
RU2072860C1 |
METHOD FOR TREATING INSULIN-DEPENDENT DIABETES MELLITUS (TYPE I) | 1997 |
|
RU2112541C1 |
MEANS FOR TREATING CHRONIC DIFFUSE DISEASES OF LIVER | 1991 |
|
RU2024256C1 |
Authors
Dates
1996-02-27—Published
1994-04-07—Filed